53
Views
57
CrossRef citations to date
0
Altmetric
Original Article

Irritable Bowel Syndrome–Prognosis and Diagnostic Safety

, &
Pages 415-418 | Received 28 Nov 1984, Accepted 21 Jan 1985, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

P. S. Efskind, T. Bernklev & M. H. Vatn. (1996) A Double-Blind Placebo-Controlled Trial with Loperamide in Irritable Bowel Syndrome. Scandinavian Journal of Gastroenterology 31:5, pages 463-468.
Read now
H. Sloth & L. S. Jørgensen. (1989) Predictors for the Course of Chronic Non-Organic Upper Abdominal Pain. Scandinavian Journal of Gastroenterology 24:4, pages 440-444.
Read now

Articles from other publishers (54)

Miriam Goebel-Stengel & Andreas Stengel. 2020. DGIM Innere Medizin. DGIM Innere Medizin 1 8 .
Yaoliang Lai, Xiao Liang, Heng Fan, Yujin Liu, Liang Zheng, Weimin Lu, Yuling Sun, Dawei Huang, Xingxing Liu, Lijian Zhang, Dongmei Zuo, Zhexing Shou, Qing Tang, Yuanyuan Wang, Zhen Li, Zhengyan Jiang, Shuo Zang, Huisuo Huang, Zongxiang Tang, Qian Li & Jun Xiao. (2022) Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial. Complementary Therapies in Medicine 68, pages 102839.
Crossref
P. Layer, V. Andresen, H. Allescher, S. C. Bischoff, M. Claßen, S. Elsenbruch, M. Freitag, T. Frieling, M. Gebhard, M. Goebel-Stengel, W. Häuser, G. Holtmann, J. Keller, M. E. Kreis, W. Kruis, J. Langhorst, P. Lynen Jansen, A. Madisch, H. Mönnikes, S. Müller-Lissner, B. Niesler, C. Pehl, D. Pohl, M. Raithel, G. Röhrig-Herzog, M. Schemann, S. Schmiedel, J. Schwille-Kiuntke, M. Storr, J. C. Preiß, T. Andus, S. Buderus, U. Ehlert, M. Engel, A. Enninger, W. Fischbach, A. Gillessen, J. Gschossmann, F. Gundling, S. Haag, U. Helwig, S. Hollerbach, M. Karaus, M. Katschinski, H. Krammer, R. Kuhlbusch-Zicklam, H. Matthes, D. Menge, S. Miehlke, M. C. Posovszky, R. Schaefert, A. Schmidt-Choudhury, O. Schwandner, A. Schweinlin, H. Seidl, A. Stengel, J. Tesarz, I. van der Voort, W. Voderholzer, G. von Boyen, J. von Schönfeld & T. Wedel. (2021) Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Zeitschrift für Gastroenterologie 59:12, pages 1323-1415.
Crossref
Liang Zheng, Weimin Lu, Qi Xiao, Yaoliang Lai, Heng Fan, Yuling Sun, Dawei Huang, Yuanyuan Wang, Zhen Li, Zhengyan Jiang, Xingxing Liu, Lijuan Zhang, Dongmei Zuo, Zhexing Shou, Qing Tang, Huisuo Huang, Yongqiang Yang, Zongxiang Tang & Jun Xiao. (2021) Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial. Scientific Reports 11:1.
Crossref
E.M. Eikelboom, L.M. Tak, A.M. Roest & J.G.M. Rosmalen. (2016) A systematic review and meta-analysis of the percentage of revised diagnoses in functional somatic symptoms. Journal of Psychosomatic Research 88, pages 60-67.
Crossref
K.‐S. Ng, N. Nassar, K. Hamd, A. Nagarajah & M. A. Gladman. (2015) Prevalence of functional bowel disorders and faecal incontinence: an Australian primary care survey. Colorectal Disease 17:2, pages 150-159.
Crossref
Roy Dekel, Douglas A. Drossman & Ami D. Sperber. 2015. Chronic Abdominal Pain. Chronic Abdominal Pain 59 67 .
Hans Törnblom & Greger Lindberg. (2011) A 21st Century Look at the Spectrum of Gastrointestinal Motility Disorders. What is Dysmotility; What is Functional?. Gastroenterology Clinics of North America 40:4, pages 715-723.
Crossref
M Nørgaard, D K Farkas, L Pedersen, R Erichsen, Z D de la Cour, H Gregersen & H T Sørensen. (2011) Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study. British Journal of Cancer 104:7, pages 1202-1206.
Crossref
Rok Seon Choung & G. Richard LockeIIIIII. (2011) Epidemiology of IBS. Gastroenterology Clinics of North America 40:1, pages 1-10.
Crossref
Kok-Ann Gwee, Young-Tae Bak, Uday Chand Ghoshal, Sutep Gonlachanvit, Oh Young Lee, Kwong Ming Fock, Andrew Seng Boon Chua, Ching-Liang Lu, Khean-Lee Goh, Chomsri Kositchaiwat, Govind Makharia, Hyo-Jin Park, Full-Young Chang, Shin Fukudo, Myung-Gyu Choi, Shobna Bhatia, Meiyun Ke, Xiaohua Hou & Michio Hongo. (2010) Asian consensus on irritable bowel syndrome. Journal of Gastroenterology and Hepatology 25:7, pages 1189-1205.
Crossref
Robin Spiller. (2010) The Pro Argument. Clinical Gastroenterology and Hepatology 8:2, pages 125-129.
Crossref
Jenny Gunnarsson & Magnus Simrén. (2008) Efficient diagnosis of suspected functional bowel disorders. Nature Clinical Practice Gastroenterology & Hepatology 5:9, pages 498-507.
Crossref
Kevin W. Olden. (2008) PEOPLE WITH FUNCTIONAL GI DISORDERS: DO THEY GET BETTER WITH TIME?. Evidence-Based Gastroenterology 9:1, pages 11-12.
Crossref
Robin Spiller. (2007) Clinical update: irritable bowel syndrome. The Lancet 369:9573, pages 1586-1588.
Crossref
F. MEARIN, X. BADIA, A. BALBOA, J. BENAVENT, A. M. CABALLERO, E. DOMINGUEZ-MUNOZ, V. GARRIGUES, J. M. PIQUE, M. ROSET, M. CUCALA & M. FIGUERAS. (2006) Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients. Alimentary Pharmacology and Therapeutics 23:6, pages 815-826.
Crossref
. 2006. Pediatric Gastrointestinal Disorders. Pediatric Gastrointestinal Disorders 117 126 .
Brennan M.R. Spiegel, Ian M. Gralnek, Roger Bolus, Lin Chang, Gareth S. Dulai, Bruce Naliboff & Emeran A. Mayer. (2005) Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome?. Gastrointestinal Endoscopy 62:6, pages 892-899.
Crossref
M. Delvaux & G. Gay. (2005) Stratégie thérapeutique chez les patients atteints du syndrome de l’intestin irritableTherapeutic strategy in patients with irritable bowel syndrome. Acta Endoscopica 35:4, pages 649-661.
Crossref
P J Matthews & Q Aziz. (2005) Functional abdominal pain. Postgraduate Medical Journal 81:957, pages 448-455.
Crossref
Filippo Cremonini & Nicholas J. Talley. (2005) Irritable Bowel Syndrome: Epidemiology, Natural History, Health Care Seeking and Emerging Risk Factors. Gastroenterology Clinics of North America 34:2, pages 189-204.
Crossref
Enrico Corazziari. (2004) Definition and epidemiology of functional gastrointestinal disorders. Best Practice & Research Clinical Gastroenterology 18:4, pages 613-631.
Crossref
Michel Delvaux & Gérard Gay. (2004) Définition des troubles fonctionnels digestifs par les critères de Rome : quelle utilité pour le clinicien ?. Gastroentérologie Clinique et Biologique 28:6-7, pages 551-553.
Crossref
H. B. El-Serag, P. Pilgrim & P. Schoenfeld. (2004) Natural history of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 19:8, pages 861-870.
Crossref
Charles D. Gerson & Mary-Joan Gerson. (2003) A collaborative health care model for the treatment of irritable bowel syndrome. Clinical Gastroenterology and Hepatology 1:6, pages 446-452.
Crossref
Samuel C. Somers & Anthony Lembo. (2003) Irritable bowel syndrome: evaluation and treatment. Gastroenterology Clinics of North America 32:2, pages 507-529.
Crossref
Natasha A. Koloski, Nicholas J. Talley & Philip M. Boyce. (2003) Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community cohort study. The American Journal of Gastroenterology 98:4, pages 789-797.
Crossref
Amir Garakani, Terrance Win, Subhdeep Virk, Sanjay Gupta, David Kaplan & Prakash S. Masand. (2003) Comorbidity of Irritable Bowel Syndrome in Psychiatric Patients: A Review. American Journal of Therapeutics 10:1, pages 61-67.
Crossref
W. G. Thompson. (2002) The treatment of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 16:8, pages 1395-1406.
Crossref
M. Camilleri, R. C. Heading & W. G. Thompson. (2002) Consensus report: clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 16:8, pages 1407-1430.
Crossref
Tony J. Lembo & Rebecca N. Fink. (2002) Clinical Assessment of Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 35:Supplement, pages S31-S36.
Crossref
Michel Delvaux. (2002) Do we need to perform rectal distention tests to diagnose IBS in clinical practice?. Gastroenterology 122:7, pages 2075-2078.
Crossref
Richard B Birrer. (2002) Irritable bowel syndrome. Disease-a-Month 48:2, pages 101-143.
Crossref
C. Beglinger, L. Degen, M. von Flüe, F. Harder, W. Langewitz, W. R. Marti, D. Oertli & M. Zuber. 2002. Praxis der Viszeralchirurgie. Praxis der Viszeralchirurgie 495 556 .
Douglas A. Drossman. (2001) Irritable bowel syndrome: How far do you go in the workup?. Gastroenterology 121:6, pages 1512-1515.
Crossref
NICHOLAS J. TALLEY & NATASHA KOLOSKI. 2000. Women and Health. Women and Health 1098 1109 .
Max W Schmulson & Lin Chang. (1999) Diagnostic approach to the patient with irritable bowel syndrome. The American Journal of Medicine 107:5, pages 20-26.
Crossref
S J Vanner, W T Depew, W G Paterson, L R DaCosta, A G Groll, J B Simon & M Djurfeldt. (1999) Predictive Value of The Rome Criteria for Diagnosing The Irritable Bowel Syndrome. American Journal of Gastroenterology 94:10, pages 2912-2917.
Crossref
Jamshid S. Kalantar & G. Richard LockeIIIIII. (1999) Disease-Specific Outcomes Assessment for Irritable Bowel Syndrome. Gastrointestinal Endoscopy Clinics of North America 9:4, pages 685-695.
Crossref
E.P. DiMagno. (1999) Pancreatic cancer: Clinical presentation, pitfalls and early clues. Annals of Oncology 10, pages S140-S142.
Crossref
Peter HerschbachPeter Herschbach. 1999. Gesundheitsverhalten. Gesundheitsverhalten 108 123 .
M. Rodwan Hiba & Richard W. McCallum. (1998) PSYCHOLOGICAL MANIFESTATIONS OF GASTROINTESTINAL DISORDERS. Gastroenterology Clinics of North America 27:4, pages 893-903.
Crossref
Richard B. Lynn & Lawrence S. Friedman. (1995) Irritable bowel syndrome : Managing the Patient with Abdominal Pain and Altered Bowel Habits. Medical Clinics of North America 79:2, pages 373-390.
Crossref
Lise Kay, Torben Jørgensen & Kirsten Hougaard Jensen. (1994) Epidemiology of abdominal symptoms in a random population: Prevalence, incidence, and natural history. European Journal of Epidemiology 10:5, pages 559-566.
Crossref
L. KAY, T. JØRGENSEN & K. H. JENSEN. (2009) The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. Journal of Internal Medicine 236:1, pages 23-30.
Crossref
J.R. Barton. (2016) Investigation and Surgery in Irritable Bowel Syndrome — A Cautionary Series. Scottish Medical Journal 39:3, pages 80-81.
Crossref
D. L. VERMILLION & S. M. COLLINS. (2008) The non‐specific induction of mastocytosis in rat intestinal muscle. Neurogastroenterology & Motility 5:1, pages 1-8.
Crossref
Douglas A. Drossman & W. Grant Thompson. (1992) The Irritable Bowel Syndrome: Review and a Graduated Multicomponent Treatment Approach. Annals of Internal Medicine 116:12_Part_1, pages 1009-1016.
Crossref
W. Grant Thompson. 1992. Modern Concepts in Gastroenterology Volume 3. Modern Concepts in Gastroenterology Volume 3 157 166 .
Krishnaiyer Subramani & Henry D. Janowitz. (1991) The Irritable Bowel Syndrome. Gastroenterology Clinics of North America 20:2, pages 363-367.
Crossref
William E. Whitehead & Michael D. Crowell. (1991) Psychologic Considerations in the Irritable Bowel Syndrome. Gastroenterology Clinics of North America 20:2, pages 249-267.
Crossref
W.G. Thompson. (1991) Symptomatic Presentations of the Irritable Bowel Syndrome. Gastroenterology Clinics of North America 20:2, pages 235-247.
Crossref
Robert C. Smith, David S. Greenbaum, Jeffery B. Vancouver, Rebecca C. Henry, Mary Ann Reinhart, Ruth B. Greenbaum, Howard A. Dean & James E. Mayle. (1990) Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome. Gastroenterology 98:2, pages 293-301.
Crossref
John E. Kellow & Pauline M. Langeluddecke. (1989) Advances in the understanding and management of the irritable bowel syndrome. Medical Journal of Australia 151:2, pages 92-99.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.